• Company
  • Description
  • Recovery Amount
  • GlaxoSmithKline
  • U.S. ex rel. Graydon v. GlaxoSmithKline
  • $1.04 billion


District of Massachusetts

G&E represented one of several whistleblowers in a case against pharmaceutical giant GlaxoSmithKline (GSK) that resulted in a $1.04 billion recovery for the federal and state governments. The suit arose from alleged misrepresentation by GSK in its promotion of the company’s popular asthma and Chronic Obstructive Pulmonary Disease (COPD) medication, Advair.